WFM
ATRS

Wilmington Funds Management’s Antares Pharma, Inc. ATRS Stock Holding History

Wilmington Funds Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,950
Closed -$45K – 837
2014
Q1 		$45K Hold
12,950
– – ﹤0.01% 757
2013
Q4 		$58K Buy
+12,950
New +$52.8K 0.01% 771

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Wilmington Funds Management's ATRS Position: Q2 2014 in Review

Wilmington Funds Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2014, closing a stake of 12,950 shares — an estimated $45K sold.

Wilmington Funds Management first reported a position in ATRS in Q4 2013 and held it in 2 quarters. The position peaked at $58K in Q4 2013. 85 funds tracked by Wall St. Rank hold ATRS as of Q2 2014.

  • Wilmington Funds Management reported no remaining Antares Pharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 12,950 Antares Pharma, Inc. shares in Q2 2014, an estimated $45K.
  • Wilmington Funds Management first reported a position in Antares Pharma, Inc. in Q4 2013 and held it in 2 quarters.
  • Wilmington Funds Management's Antares Pharma, Inc. position peaked at $58K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.